Non-medical opioid use and sources of opioids among pregnant and non-pregnant reproductive-aged women

Drug and Alcohol Dependence

Volumn 174, Issue , 2017, Pages 201-208

  Kozhimannil, Katy B ^a   Graves, Amy J ^a   Jarlenski, Marian ^b   Kennedy Hendricks, Alene ^c   Gollust, Sarah ^a   Barry, Colleen L ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Maternal and child health; Pregnancy; Prescription opioids; Women's health

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEALTH IMPACT ASSESSMENT; HUMAN; NAMED GROUPS OF PERSONS; NON MEDICAL OPIOID USE; NON PREGNANT REPRODUCTIVE AGED WOMAN; OPIATE ADDICTION; OUTCOME ASSESSMENT; PREGNANT WOMAN; PRESCRIPTION; UNITED STATES; WOMEN'S HEALTH; ADOLESCENT; CROSS-SECTIONAL STUDY; DRUG MISUSE; PREGNANCY; YOUNG ADULT;

NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; OPIOID-RELATED DISORDERS; PREGNANCY; PRESCRIPTION DRUG MISUSE; PRESCRIPTIONS; UNITED STATES; YOUNG ADULT;

EID: 85017524545     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.01.003     Document Type: Article

References (45)

1. ACOG Committee on Health Care for Underserved Women and American Society of Addiction Medicine, ACOG committee opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet. Gynecol. 119 (2012), 1070–1076, 10.1097/AOG.0b013e318256496e.
2. Ailes, E.C., Dawson, A.L., Lind, J.N., Gilboa, S.M., Frey, M.T., Broussard, C.S., Honein, M.A., Centers for Disease Control and Preventon, 2015. Opioid prescription claims among women of reproductive age–United States, 2008–2012. MMWR 64 (2012), 37–41 (Accessed 24 August 2016) http://www.ncbi.nlm.nih.gov/pubmed/25611168.
3. Bartels, K., Mayes, L.M., Dingmann, C., Bullard, K.J., Hopfer, C.J., Binswanger, I.A., Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS One, 11, 2016, e0147972, 10.1371/journal.pone.0147972.
4. Committee on Health Care for Underserved Women and The American College of Obstetricians and Gynecologists, Committee opinion No. 538: nonmedical use of prescription drugs. Obstet. Gynecol. 120 (2012), 977–982, 10.1097/AOG.0b013e3182723b5a.
5. Creanga, A., Sabel, J.C., Ko, J.Y., Wasserman, C.R., Shapiro-Mendoza, C.K., Taylor, P., Barfield, W., Cawthon, L., Paulozzi, L.J., Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet. Gynecol. 119 (2012), 924–933, 10.1097/AOG.0b013e31824ea276.
6. Curtin, S.C., Abma, J.C., Ventura, S.J., Henshaw, S.K., Pregnancy rates for U.S. women continue to drop. NCHS Data Brief 136 (2013), 1–8 http://www.ncbi.nlm.nih.gov/pubmed/24314113.
7. De'souza, V., Prenatal Drug Use and Newborn Health: Federal Efforts Need Better Planning and Coordination GAO-15-203. 2015, Government Accountability Office, Washington, D.C.
8. Desai, R.J., Hernandez-Diaz, S., Bateman, B.T., Huybrechts, K.F., Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstet. Gynecol. 123 (2014), 997–1002, 10.1097/AOG.0000000000000208.
9. Dowell, D., Haegerich, T.M., Chou, R., CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA 315 (2016), 1624–1645, 10.1001/jama.2016.1464.
10. Evans, E., Kelleghan, A., Li, L., Min, J., Huang, D., Urada, D., Hser, Y., Nosyk, B., Gender differences in mortality among treated opioid dependent patients. Drug Alcohol Depend. 155 (2015), 228–235, 10.1016/j.drugalcdep.2015.07.010.
11. Finer, L.B., Zolna, M.R., Declines in unintended pregnancy in the United States, 2008–2011. N. Engl. J. Med. 374 (2016), 843–852, 10.1056/NEJMsa1506575.
12. Guttmacher Institute, State Policies In Brief: Substance Abuse During Pregnancy. Washington, DC. 2016 (Accessed 24 August 2016) https://www.guttmacher.org/sites/default/files/pdfs/spibs/spib_SADP.pdf.
13. Hall, M.T., Wilfong, J., Huebner, R.A., Posze, L., Willauer, T., Medication-assisted treatment improves child permanency outcomes for opioid-using families in the child welfare system. J. Subst. Abuse Treat. 71 (2016), 63–67, 10.1016/j.jsat.2016.09.006.
14. Heil, S.H., Jones, H.E., Arria, A., Kaltenbach, K., Coyle, M., Fischer, G., Stine, S., Selby, P., Martin, P.R., Unintended pregnancy in opioid-abusing women. J. Subst. Abuse Treat. 40 (2011), 199–202, 10.1016/j.jsat.2010.08.011.
15. Kattan, J.A., Tuazon, E., Paone, D., Dowell, D., Vo, L., Starrels, J.L., Jones, C.M., Kunins, H.V., Public health detailing—a successful strategy to promote judicious opioid analgesic prescribing. Am. J. Public Health 106 (2016), 1430–1438, 10.2105/AJPH.2016.303274.
16. Kennedy-Hendricks, A., Gielen, A., McDonald, E., McGinty, E.E., Shields, W., Barry, C.L., Medication sharing, storage, and disposal practices for opioid medications among us adults. JAMA Intern. Med., 6, 2016, 1027, 10.1001/jamainternmed.2016.2543.
17. Kennedy-Hendricks, A., McGinty, E.E., Barry, C.L., Effects of competing narratives on public perceptions of opioid pain reliever addiction during pregnancy. J. Health Polit. Policy Law 41 (2016), 873–916, 10.1215/03616878-3632230.
18. Kerridge, B.T., Saha, T.D., Chou, S.P., Zhang, H., Jung, J., Ruan, W.J., Smith, S.M., Huang, B., Hasin, D.S., Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions − III. Drug Alcohol Depend. 156 (2015), 47–56, 10.1016/j.drugalcdep.2015.08.026.
19. Kessler, R.C., Barker, P.R., Colpe, L.J., Epstein, J.F., Gfroerer, J.C., Hiripi, E., Howes, M.J., Normand, S.L., Manderscheid, R.W., Walters, E.E., Zaslavsky, A.M., Screening for serious mental illness in the general population. Arch. Gen. Psychiatry 60 (2003), 184–189 (Accessed 24 August 2016) http://www.ncbi.nlm.nih.gov/pubmed/12578436.
20. King, N.B., Fraser, V., Boikos, C., Richardson, R., Harper, S., Determinants of increased opioid-related mortality in the United States and Canada, 1990–2013: a systematic review. Anesthesiology 311 (2014), 367–370, 10.3109/00952990.2015.1047502.
21. Ko, J.Y., Farr, S.L., Tong, V.T., Creanga, A.A., Callaghan, W.M., Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am. J. Obstet. Gynecol. 213:201 (2015), e1–e201, 10.1016/j.ajog.2015.03.021.
22. Krans, E.E., Patrick, S.W., Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic. Obstet. Gynecol. 128 (2016), 4–10, 10.1097/AOG.1.0000000000001446.
23. Mack, K.A., Centers for Disease Control and Prevention (CDC), Centers for disease control and prevention (CDC), 2013. drug-induced deaths − United States, 1999–2010. MMWR, 2013, 161–163 (Accessed 24 August 2016) http://www.ncbi.nlm.nih.gov/pubmed/24264508.
24. Maeda, A., Bateman, B.T., Clancy, C.R., Creanga, A., Leffert, L.R., Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology 121 (2014), 1158–1165, 10.1097/ALN.;1;0000000000000472.
25. Maughan, B.C., Hersh, E.V., Shofer, F.S., Wanner, K.J., Archer, E., Carrasco, L.R., Rhodes, K.V., Unused opioid analgesics and drug disposal following outpatient dental surgery: a randomized controlled trial. Drug Alcohol Depend. 168 (2016), 328–334, 10.1016/j.drugalcdep.2016.08.016.
26. McQueen, K.A., Murphy-Oikonen, J., Desaulniers, L., Maternal substance use and neonatal abstinence syndrome: a descriptive study. Matern. Child Health J. 19 (2015), 1756–1765, 10.1007/s10995-015-1689-y.
27. Overbeek, A., van den Berg, M.H., Hukkelhoven, C.W., Kremer, L.C., van den Heuvel-Eibrink, M.M., Tissing, W.J., Loonen, J.J., Versluys, A.B., Bresters, D., Kaspers, G.J., Lambalk, C.B., van Leeuwen, F.E., van Dulmen-den Broeder, E., DCOG LATER/VEVO Study Group, Validity of self-reported data on pregnancies for childhood cancer survivors: a comparison with data from a nationwide population-based registry. Hum. Reprod. 28 (2013), 819–827, 10.1093/humrep/des405.
28. Pan, I.J., Yi, H.Y., Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: united States, 1999–2008. Matern. Child Health J. 17 (2013), 667–676, 10.1007/s10995-012-1046-3.
29. Patrick, S.W., Schumacher, R.E., Benneyworth, B.D., Krans, E.E., McAllister, J.M., Davis, M.M., Neonatal abstinence syndrome and associated health care expenditures, United States, 2000–2009. JAMA 307 (2012), 1934–1940, 10.1001/jama.2012.3951.
30. Patrick, S.W., Davis, M.M., Lehman, C.U., Cooper, W.O., Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012. J. Perinatol., 35, 2015, 667, 10.1038/jp.2015.63.
31. Patrick, S.W., Dudley, J., Martin, P.R., Harrell, F.E., Warren, M.D., Hartmann, K.E., Ely, E.W., Grijalva, C.G., Cooper, W.O., Prescription opioid epidemic and infant outcomes. Pediatrics 135 (2015), 842–850, 10.1542/peds.2014-3299.
32. Patrick, S.W., Fry, C.E., Jones, T.F., Buntin, M.B., Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff. (Millwood) 35 (2016), 1324–1332, 10.1377/hlthaff.2015.1496.
33. Roberts, S.C.M., Pies, C., Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care. Matern. Child Health J. 15 (2011), 333–341, 10.1007/s10995-010-0594-7.
34. Saloner, B., Bandara, S.N., McGinty, E.E., Barry, C.L., Justice-involved adults with substance use disorders: coverage increased but rates of treatment did not in 2014. Health Aff. (Millwood) 35 (2016), 1058–1066, 10.1377/hlthaff.2016.0005.
35. Stine, S.M., Heil, S.H., Kaltenbach, K., Martin, P.R., Coyle, M.G., Fischer, G., Arria, A.M., Selby, P., Jones, H.E., Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER Study. Am. J. Drug Alcohol Abuse 35 (2009), 429–433, 10.3109/00952990903374080.
36. Substance Abuse and Mental Health Services Administration, 2014 National Survey on Drug Use and Heath: Field Interviewer Manual. Rockville, MD. 2013 http://www.samhsa.gov/data/sites/default/files/NSDUHmrbFImanual2014_opt.pdf.
37. Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings NSDUH Series H-41. 2014, HHS Publication No. (SMA), 11–4658.
38. Substance Abuse and Mental Health Services Administration, 2014 National Survey on Drug Use and Health: Methodological Summary and Definitions Rockville, MD. 2015 http://www.samhsa.gov/data/sites/default/files/NSDUH-MethodSummDefs2014/NSDUH-MethodSummDefs2014.htm#b3-1.
39. Terplan, M., Kennedy-Hendricks, A., Chisolm, M.S., Prenatal substance use: exploring assumptions of maternal unfitness. Subst. Abuse 9:Suppl. 2 (2015), 1–4, 10.4137/SART.S23328.
40. Terplan, M., Longinaker, N., Appel, L., Women-centered drug treatment services and need in the United States, 2002–2009. Am. J. Public Health 105 (2015), e50–e54, 10.2105/ajph.2015.302821.
41. Tetrault, J.M., Desai, R.A., Becker, W.C., Fiellin, D.A., Concato, J., Sullivan, L.E., Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 103 (2008), 258–268, 10.1111/j.1360-0443.2007.02056.x.
42. Tolia, V.N., Patrick, S.W., Bennett, M.M., Muthy, K., Sousa, J., Smith, B., Clark, R.H., Spitzer, A.R., Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N. Engl. J. Med. 372 (2015), 2118–2126, 10.1056/NEJMsa1500439.
43. US Centers for Disesase Control and Prevention. Prescription Painkiller Overdoses | VitalSigns. https://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/index.html. Accessed 20 December 2016.
44. Warren, M.D., Miller, A.M., Traylor, J., Bauer, A., Patrick, S.W., Implementation of a statewide surveillance system for neonatal abstinence syndrome ? Tennessee. MMWR 64 (2013), 125–128 (Accessed 21 March 2016) http://www.ncbi.nlm.nih.gov/pubmed/25674995.
45. Young, N.K., Boles, S.M., Otero, C., Parental substance use disorders and child maltreatment: overlap, gaps, and opportunities. Child Maltreat. 12 (2007), 137–149, 10.1177/1077559507300322.